全文获取类型
收费全文 | 3210篇 |
免费 | 119篇 |
国内免费 | 181篇 |
专业分类
耳鼻咽喉 | 40篇 |
儿科学 | 63篇 |
妇产科学 | 24篇 |
基础医学 | 142篇 |
口腔科学 | 79篇 |
临床医学 | 150篇 |
内科学 | 509篇 |
皮肤病学 | 3篇 |
神经病学 | 44篇 |
特种医学 | 169篇 |
外科学 | 1333篇 |
综合类 | 579篇 |
预防医学 | 71篇 |
眼科学 | 50篇 |
药学 | 80篇 |
中国医学 | 24篇 |
肿瘤学 | 150篇 |
出版年
2023年 | 21篇 |
2022年 | 22篇 |
2021年 | 23篇 |
2020年 | 32篇 |
2019年 | 40篇 |
2018年 | 19篇 |
2017年 | 20篇 |
2016年 | 39篇 |
2015年 | 36篇 |
2014年 | 41篇 |
2013年 | 33篇 |
2012年 | 81篇 |
2011年 | 166篇 |
2010年 | 87篇 |
2009年 | 93篇 |
2008年 | 125篇 |
2007年 | 128篇 |
2006年 | 129篇 |
2005年 | 162篇 |
2004年 | 332篇 |
2003年 | 278篇 |
2002年 | 311篇 |
2001年 | 184篇 |
2000年 | 109篇 |
1999年 | 143篇 |
1998年 | 127篇 |
1997年 | 136篇 |
1996年 | 76篇 |
1995年 | 82篇 |
1994年 | 65篇 |
1993年 | 57篇 |
1992年 | 57篇 |
1991年 | 45篇 |
1990年 | 52篇 |
1989年 | 36篇 |
1988年 | 25篇 |
1987年 | 28篇 |
1986年 | 18篇 |
1985年 | 7篇 |
1984年 | 5篇 |
1983年 | 2篇 |
1981年 | 4篇 |
1980年 | 2篇 |
1979年 | 3篇 |
1978年 | 2篇 |
1977年 | 3篇 |
1975年 | 5篇 |
1974年 | 9篇 |
1973年 | 2篇 |
1961年 | 1篇 |
排序方式: 共有3510条查询结果,搜索用时 15 毫秒
101.
Dignan FL Amrolia P Clark A Cornish J Jackson G Mahendra P Scarisbrick JJ Taylor PC Shaw BE Potter MN;Haemato-oncology Task Force of British Committee for Standards in Haematology;British Society for Blood Marrow Transplantation 《British journal of haematology》2012,158(1):46-61
A joint working group established by the Haemato-oncology subgroup of the British Committee for Standards in Haematology (BCSH) and the British Society for Bone Marrow Transplantation (BSBMT) has reviewed the available literature and made recommendations for the diagnosis and management of chronic graft-versus-host disease (GvHD). This guideline includes recommendations for the diagnosis and staging of chronic GvHD as well as primary treatment and options for patients with steroid-refractory disease. The goal of treatment should be the effective control of GvHD while minimizing the risk of toxicity and relapse. 相似文献
102.
Diagnosis and management of acute graft-versus-host disease 总被引:1,自引:0,他引:1
Dignan FL Clark A Amrolia P Cornish J Jackson G Mahendra P Scarisbrick JJ Taylor PC Hadzic N Shaw BE Potter MN;Haemato-oncology Task Force of British Committee for Standards in Haematology;British Society for Blood Marrow Transplantation 《British journal of haematology》2012,158(1):30-45
A joint working group established by the Haemato-oncology subgroup of the British Committee for Standards in Haematology (BCSH) and the British Society for Bone Marrow Transplantation (BSBMT) has reviewed the available literature and made recommendations for the diagnosis and management of acute graft-versus-host disease. This guideline includes recommendations for the diagnosis and grading of acute graft-versus-host disease as well as primary treatment and options for patients with steroid-refractory disease. The goal of treatment should be effective control of graft-versus-host disease while minimizing risk of toxicity and relapse. 相似文献
103.
Levine GN Steinke EE Bakaeen FG Bozkurt B Cheitlin MD Conti JB Foster E Jaarsma T Kloner RA Lange RA Lindau ST Maron BJ Moser DK Ohman EM Seftel AD Stewart WJ;American Heart Association Council on Clinical Cardiology;Council on Cardiovascular Nursing;Council on Cardiovascular Surgery Anesthesia;Council on Quality of Care Outcomes Research 《Circulation》2012,125(8):1058-1072
104.
Passweg JR Baldomero H Gratwohl A Bregni M Cesaro S Dreger P de Witte T Farge-Bancel D Gaspar B Marsh J Mohty M Peters C Tichelli A Velardi A de Elvira CR Falkenburg F Sureda A Madrigal A;European Group for Blood Marrow Transplantation 《Bone marrow transplantation》2012,47(7):906-923
A total of 654 centers from 48 countries were contacted for the 2010 survey. In all, 634 centers reported a total of 33?362 hematopoietic SCT (HSCT) with 30?012 patients receiving their first transplant (12?276 allogeneic (41%) and 17?736 autologous (59%)). Main indications were leukemias: 9355 (31%; 93% allogeneic), lymphoid neoplasias specifically Non Hodgkin's lymphoma, Hodgkin's lymphoma and plasma cell disorders: 17?362 (58%; 12% allogeneic), solid tumors: 1585 (5%; 6% allogeneic) and non-malignant disorders: 1609 (6%; 88% allogeneic). There were more unrelated donors than HLA-identical sibling donors (53% versus 41%); the proportion of peripheral blood as stem cell source was 99% for autologous and 71% for allogeneic HSCT. Cord blood was primarily used in allogeneic transplants (6% of total) with three autologous cord blood HSCT being reported. The number of transplants has increased by 19% since 2005 (allogeneic 37% and autologous 9%) and continued to increase by about 1100 HSCT per year since 2000. Patterns of increase were distinct and different. The data show the development of transplantation in Europe since 1990, with the number of patients receiving a HSCT increasing from 4200 to over 30?000 annually. The most impressive trend seen is the steady increase of unrelated donor transplantation, in parallel to the availability of unrelated donors through donor registries. 相似文献
105.
M. Kasahara K. Umeshita Y. Inomata S. Uemoto Japanese Liver Transplantation Society 《American journal of transplantation》2013,13(7):1830-1839
The Japanese Liver Transplantation Society (JLTS) was established in 1980 in order to characterize and follow trends in patient characteristics and graft survival among all liver transplant patients in Japan. This study analyzed the comprehensive factors that may influence the outcomes of pediatric patients who undergo living donor liver transplantation (LDLT) by evaluating the largest cohort in the world. Between November 1989 and December 2010, 2224 pediatric patients underwent LDLT in Japan. There were 998 male (44.9%) and 1226 female donors (55.1%) without donor mortalities related to transplant surgery. There were 946 male (42.5%) and 1278 female (57.5%) recipients with a median age of 4.0 years (range: 13 days to 17.9 years). Cholestatic liver disease was the leading indication for LDLT (n = 1649; 76.2%), followed by metabolic disorders (n = 194; 8.7%), acute liver failure (n = 192; 8.6%) and neoplastic liver disease (n = 66; 3.0%). The 1‐, 5‐, 10‐ and 20‐year patient survival rates were 88.3%, 85.4%, 82.8% and 79.6%, respectively. Blood‐type incompatibility, recipient age, etiology of liver disease and transplant era were found to be significant predictors of overall survival. We are able to achieve satisfactory long‐term pediatric patient survival outcomes in the JLTS series without compromising the living donors. 相似文献
106.
Benoit Mesnard Maxime Leroy James Hunter Delphine Kervella Marc-Olivier Timsit Lionel Badet Pascal Glemain Emmanuel Morelon Fanny Buron Moglie Le Quintrec-Donnette Vincent Pernin Marc Ladriere Sophie Girerd Christophe Legendre Antoine Sicard Laeticia Albano Stephane De Vergie Clarisse Kerleau Thomas Prudhomme Jérôme Rigaud Diego Cantarovich Gilles Blancho Georges Karam Magali Giral Simon Ville Julien Branchereau For the Données Informatisées et VAlidées en Transplantation/Computerized VAlidated Data in Transplantation Consortium Affiliations† 《BJU international》2022,129(2):225-233
107.
Daniel?Junker Thomas?R.?W.?Herrmann Markus?Bader Jasmin?Bektic Gregor?Henkel Stephan?Kruck Markus?Sandbichler David?Schilling Georg?Sch?fer Udo?Nagele the Training Research in Urological Surgery Therapy group 《World journal of urology》2016,34(2):245-252
Introduction
Experience from interdisciplinary cooperation revealed the need for a prostate mapping scheme to communicate multiparametric MRI (mpMRI) findings between radiologists, urologists, and pathologists, which should be detailed, yet easy to memorize. For this purpose, the ‘Prostate interdisciplinary communication and mapping algorithm for biopsy and pathology’ (PIC-MABP) was developed. This study evaluated the accuracy of the PIC-MABP system.Methods
PIC-MABP was tested and validated in findings of 10 randomly selected patients from routine clinical practise with 18 histologically proven cancer lesions. Patients received an mpMRI of the prostate prior to prostatectomy. After surgery the prostates were prepared as whole-mount step sections. Cancer lesions, which were found suspicious on mpMRI, were assigned to the according PIC-MABP sectors by a radiologist. MpMRI slides were masked and sent to seven urologists from different centres, providing only the PIC-MABP location of each lesion. Urologists marked the accordant regions. Then mpMRI slides were unmasked, and the correctness of each mark was evaluated.Results
One hundred and seventeen of the 126 marks (93 %) were correctly assigned. Detection rates differed for lesions >0.5 cc compared with lesions <0.5 cc (p < 0.005): 3/7 (43 %) marks were correctly assigned in lesions <0.3 cc, 16/21 (76 %) in lesions with 0.3–0.5 cc, and 98/98 (100 %) in lesions >0.5 cc. Interobserver agreement was good for lesions >0.5 cc and poor for lesions <0.3 cc (Fleiss Kappa 1 vs. 0.0175).Conclusion
PIC-MABP seems to be a reliable system to communicate the location of mpMRI findings >0.5 cc between different disciplines and can be a useful guidance for cognitive mpMRI/TRUS fusion biopsy.108.
Toll-like receptor interactions: tolerance of MyD88-dependent cytokines but enhancement of MyD88-independent interferon-beta production
下载免费PDF全文
![点击此处可从《Immunology》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Broad A Kirby JA Jones DE;Applied Immunology Transplantation Research Group 《Immunology》2007,120(1):103-111
Toll-like receptors (TLRs) signal through two main pathways: a myeloid differentiation factor (MyD)88-dependent pathway that acts via nuclear factor kappaB (NF-kappaB) to induce proinflammatory cytokines such as tumour necrosis factor-alpha (TNF-alpha) and a MyD88-independent pathway that acts via type I interferons to increase the expression of interferon-inducible genes. Repeated signalling through TLR4 and a number of other TLRs has been reported to result in a reduction in the subsequent proinflammatory cytokine response, a phenomenon known as TLR tolerance. In this study we have shown that, whilst NF-kappaB activation and production of TNF-alpha and interleukin-12 by murine RAW264.7 and J774.2 cells in response to stimulation by TLR4, -5, -7 or -9, was reduced by prior stimulation with TLR4, -5, -7 or -9 ligands, the primary stimulation of TLR3, which does not use the MyD88 pathway, did not reduce the TNF-alpha or interleukin-12 responses to subsequent TLR stimulation. The response to TLR3 stimulation was not diminished by prior TLR ligand exposure. Furthermore, the production of interferon-beta (IFN-beta) following stimulation of TLR3 or -4, which is MyD88-independent, was increased by prior activation of TLR4, -5, -7 or -9. In contrast, TLR9 ligand-induced IFN-beta production, which is MyD88-dependent, was tolerized by prior TLR stimulation. These results are consistent with differential regulation of MyD88-dependent and MyD88-independent cytokine production following serial activation of TLRs. 相似文献
109.
中华医学会器官移植学分会 《中华移植杂志(电子版)》2020,14(3):129-135
目前,心肺联合移植已成为公认治疗终末期心肺疾病的有效方法。中华医学会器官移植学分会组织心脏和肺移植专家,结合当前国内外心肺联合移植形势,总结国际指南和相关研究最新进展,并结合国内临床实践经验,从心肺联合移植的适应证和禁忌证、手术时机选择、供者选择、供器官获取和保护以及手术要点和术后管理等方面制订《中国心肺联合移植操作规范(2019版)》。 相似文献
110.
Jeremy Yuen-Chun Teoh Chak-Lam Cho Yong Wei Shuji Isotani Ho-Yee Tiong Teng-Aik Ong Kittinut Kijvikai Peggy Sau-Kwan Chu Eddie Shu-Yin Chan Chi-Fai Ng the Asian Urological Surgery Training & Education Group 《Andrologia》2020,52(8):e13708
Anatomical endoscopic enucleation of the prostate has been proposed as a potentially superior benign prostatic hyperplasia surgery than conventional transurethral resection of prostate. However, the learning curve of the procedure is steep, hence limiting its generalisability worldwide. In order to overcome the learning curve, a proper surgical training is extremely important. This review article discussed about various aspects of surgical training in anatomical endoscopic enucleation of the prostate. In summary, no matter what surgical technique or energy modality you use, the principle of anatomical enucleation should be followed. When one starts to perform prostate enucleation, a 50 to 80 g prostate appears to be the ‘best case’ to begin with. Mentorship is extremely important to shorten the learning curve and to prevent drastic complications from the procedure. A proficiency-based progression training programme with the use of simulation and training models should be the best way to teach and learn about prostate enucleation. Enucleation ratio efficacy is the preferred measure for assessing skill level and learning curve of prostate enucleation. Morcellation efficiency is commonly used to assess morcellation performance, but the importance of safety rather than efficiency must be emphasised. 相似文献